Prevalence of the risk factors for QT prolongation and associated drug-drug interactions in a cohort of medical inpatients.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of the Formosan Medical Association = Taiwan yi zhi"
DOI: 10.1016/j.jfma.2018.01.016
Abstract: BACKGROUND/PURPOSE Medical inpatients are at increased risk of QT interval prolongation due to multiple risk actors and QT prolonging drugs. This study aimed to identify the prevalence of risk factors for QT prolongation; QT prolonging… read more here.
Keywords: prolonging drugs; risk; medical inpatients; risk factors ... See more keywords
The CredibleMeds® list: usage of QT interval prolonging drugs in Germany and discordances with prescribing information.
Sign Up to like & getrecommendations! Published in 2021 at "British journal of clinical pharmacology"
DOI: 10.1111/bcp.14951
Abstract: AIMS A substantial number of Summaries of Product Characteristics (SmPCs)/Prescribing Information (PI) have warnings or contraindications on QT interval prolongation. The goal of this work was to quantify usage of QT interval prolonging drugs according… read more here.
Keywords: prolonging drugs; usage interval; according crediblemeds; interval prolonging ... See more keywords
Torsade de Pointes: How Much Do Psychotropics Really Contribute?
Sign Up to like & getrecommendations! Published in 2025 at "European Psychiatry"
DOI: 10.1192/j.eurpsy.2025.413
Abstract: Introduction Based on potential risk of torsade de pointes (TdeP; a rare arrhythmia), regulatory agencies have issue warning for two specific antidepressants. This has translated in clinic as a class effect in that every antidepressant… read more here.
Keywords: prolonging drugs; left ventricular; risk; ventricular dysfunction ... See more keywords